These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6364312)

  • 1. Test of leukocyte migration inhibition. 1. Value of the test in the diagnosis of certain immune diseases.
    Urcan S; Stanciu L; Georoceanu A; Popescu S
    Med Interne; 1983; 21(3):231-4. PubMed ID: 6364312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Test of leukocyte migration inhibition. II. Comparative study of the techniques in capillary tubes and in agarose.
    Stanciu L; Urcan S; Radu D; Itu I; Popescu S
    Med Interne; 1984; 22(1):67-70. PubMed ID: 6710051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applicability of the leukocyte migration inhibition test in the clinical practice.
    Stanciu L; Dumitrescu D; Radu D
    Med Interne; 1990; 28(4):295-303. PubMed ID: 2100874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum migration-inhibitory activity in infants with respiratory syncytial virus bronchiolitis.
    Bertotto A; Stagni G; Sonaglia F; Caprino D; Vaccaro R
    Boll Ist Sieroter Milan; 1981 May; 60(2):150-4. PubMed ID: 7030363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative in vitro studies of cell-mediated immunity in chronic liver diseases].
    Königstedt B; Zipprich R; Nilius R
    Dtsch Z Verdau Stoffwechselkr; 1986; 46(2):113-21. PubMed ID: 3487441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Value of cellular immunity tests (lymphocyte transformation test and leukocyte migration test) in the detection of sensitivity to drugs].
    Harrabi S; Loiseau P; Dehenry J; Harrabi S
    Allerg Immunol (Paris); 1987 Oct; 19(8):330, 332. PubMed ID: 3453141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Studies of an assay system for dialyzable leukocyte extracts (DLE)--influence of DLE on leukocyte migration inhibition test by HBsAg].
    Hashimoto Y; Sekiguchi S
    Hokkaido Igaku Zasshi; 1985 Sep; 60(5):763-8. PubMed ID: 3908264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNCB sensitivity in healthy Pakistani subjects and patients with liver disease.
    Zuberi SJ; Siddiqui M; Ahmed SA; Kara RY
    Pahlavi Med J; 1978 Jan; 9(1):14-20. PubMed ID: 652381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Leukocyte aggregation test for assessing cell-mediated immunity: its use in drug allergy (author's transl)].
    Rouveix B
    Nouv Presse Med; 1982 Mar; 11(11):843-6. PubMed ID: 7070976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Leukocyte migration inhibitory factor and basophil degranulation in drug reactions].
    Rangel H; Montero P; Espinosa F; Castillo FJ
    Rev Alerg; 1991; 38(4):105-9. PubMed ID: 1724705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukocyte migration inhibition (LMI) by a specific antigen in human toxoplasmosis.
    Ferencz A; Nyerges G; Jankó M
    Acta Microbiol Acad Sci Hung; 1982; 29(3):209-11. PubMed ID: 7168371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Studies on the pathogenic mechanism of beta-lactam hypersensitivity by the detection of leucocyte migration activating factor and leucocyte migration inhibitory factor].
    Uno K
    Arerugi; 1990 Dec; 39(12):1605-11. PubMed ID: 2096806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cellular immunoreaction in alcohol-induced liver damage].
    Otto L; Nilius R; Busse HJ; Zipprich B
    Z Gesamte Inn Med; 1977 Jun; 32(12):271-4. PubMed ID: 910528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological monitoring in lung cancer: use of the leukocyte migration inhibition assay.
    Abai AM; Fekete B
    Haematologia (Budap); 1982; 15(1):111-25. PubMed ID: 6749608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune response to rabbit liver-specific lipoprotein in acute viral hepatitis.
    Ortona L; Laghi V; Cauda R; Nervo P
    Clin Exp Immunol; 1980 Dec; 42(3):436-40. PubMed ID: 7214740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Electrophoresis mobility inhibition test (emt) in immunological early diagnosis of gynaecological malignomas (author's transl)].
    Kreienberg R; Schütz G; Melchert F; Lemmel EM
    Geburtshilfe Frauenheilkd; 1979 Aug; 39(8):709-15. PubMed ID: 383565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The interference of an autoimmune mechanism in the pathogeny of chronic active liver diseases.
    Banciu T; Arcan P; Văcariu V; Tudose N
    Med Interne; 1989; 27(1):47-52. PubMed ID: 2749158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concurrent cell-mediated immunity and immediate hypersensitivity in animal model.
    Wolf R; Livni E; Joshua H
    Ann Allergy; 1984 Apr; 52(4):300-2. PubMed ID: 6370046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of leukocyte migration inhibition (LIF) in patients with carcinoma of the lung before and after the use of levamisole in vitro].
    Leonardo E; Malandrino M; Palestro G; De Simone M; Mancuso M; Albera C; Besso P; Cavallero M
    Minerva Med; 1980 Dec; 71(50):3665-8. PubMed ID: 7005756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The in vivo effect of thymic factor (thymostimulin) administration in Hodgkin's disease patients. Correlation of skin reactivity and leukocyte migration-inhibition factor in the sera of anergic subjects.
    Velardi A; Rambotti P; Cernetti C; Spinozzi F; Bertotto A; Martelli MF
    Thymus; 1983 Sep; 5(5-6):429-32. PubMed ID: 6362105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.